John L Griffith

Author PubWeight™ 85.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005 9.61
2 Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004 8.21
3 Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med 2002 4.24
4 Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002 3.65
5 Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003 3.48
6 Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 2012 3.41
7 Parental perspectives on end-of-life care in the pediatric intensive care unit. Crit Care Med 2002 2.81
8 Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003 2.77
9 Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008 2.44
10 An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase. Am J Med 2002 2.12
11 Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis 2011 2.01
12 The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007 2.00
13 Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008 1.92
14 Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2008 1.91
15 Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004 1.88
16 Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes 2009 1.71
17 Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes 2013 1.66
18 A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes 2011 1.63
19 The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis 2008 1.53
20 Use of the electrocardiograph-based thrombolytic predictive instrument to assist thrombolytic and reperfusion therapy for acute myocardial infarction. A multicenter, randomized, controlled, clinical effectiveness trial. Ann Intern Med 2002 1.49
21 External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol 2003 1.35
22 Improving the reliability of physician performance assessment: identifying the "physician effect" on quality and creating composite measures. Med Care 2009 1.29
23 Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes 2010 1.28
24 Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 2005 1.28
25 Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr 2002 1.26
26 Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol 2007 1.25
27 Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 2010 1.24
28 Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J 2012 1.15
29 Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci 2011 1.14
30 Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am J Med 2007 1.08
31 Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis 2010 1.05
32 Smoking cessation in primary care: a clinical effectiveness trial of two simple interventions. Prev Med 2004 1.05
33 Emergency medical service predictive instrument-aided diagnosis and treatment of acute coronary syndromes and ST-segment elevation myocardial infarction in the IMMEDIATE trial. Prehosp Emerg Care 2011 1.05
34 Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. Am J Cardiol 2007 1.01
35 Successful dissemination of a community-based strength training program for older adults by peer and professional leaders: the people exercising program. J Am Geriatr Soc 2008 0.99
36 A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol 2007 0.97
37 Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care 2007 0.96
38 Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. Am J Cardiol 2003 0.96
39 Temporal trends in health-related quality of life among hemodialysis patients in the United States. Clin J Am Soc Nephrol 2009 0.94
40 A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2008 0.89
41 The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: a multicenter study. Am J Emerg Med 2004 0.88
42 Hematocrit and left ventricular mass: the Framingham Heart study. J Am Coll Cardiol 2004 0.88
43 Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction. J Clin Epidemiol 2004 0.87
44 Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial. J Nucl Cardiol 2004 0.84
45 Tufts CTSI: comparative effectiveness research as a conceptual framework for a focus on impact. Clin Transl Sci 2010 0.80
46 Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study. Am J Emerg Med 2004 0.79